These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9155057)

  • 1. Enhancement of immunotoxin activity using chemical and biological reagents.
    Wu M
    Br J Cancer; 1997; 75(9):1347-55. PubMed ID: 9155057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant ricin A chain conjugated to monoclonal antibodies: improved tumor cell inhibition in the presence of lysosomotropic compounds.
    Ramakrishnan S; Bjorn MJ; Houston LL
    Cancer Res; 1989 Feb; 49(3):613-7. PubMed ID: 2783383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotoxin enhancers.
    Casellas P; Jansen FK
    Cancer Treat Res; 1988; 37():351-69. PubMed ID: 2908632
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetics of cytotoxicity induced by immunotoxins. Enhancement by lysosomotropic amines and carboxylic ionophores.
    Casellas P; Bourrie BJ; Gros P; Jansen FK
    J Biol Chem; 1984 Aug; 259(15):9359-64. PubMed ID: 6746651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins.
    Griffin T; Raso V
    Cancer Res; 1991 Aug; 51(16):4316-22. PubMed ID: 1868454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the cytotoxic effect of anti-carcinoembryonic antigen immunotoxins by adenovirus and carboxylic ionophores.
    Griffin TW; Childs LR; FitzGerald DJ; Levin LV
    J Natl Cancer Inst; 1987 Oct; 79(4):679-85. PubMed ID: 3498854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction.
    Jaffrézou JP; Levade T; Thurneyssen O; Chiron M; Bordier C; Attal M; Chatelain P; Laurent G
    Cancer Res; 1992 Mar; 52(5):1352-9. PubMed ID: 1737397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of antibody valency and lysosomotropic amines on the synergy between ricin A chain- and ricin B chain-containing immunotoxins.
    Fulton RJ; Uhr JW; Vitetta ES
    J Immunol; 1986 Apr; 136(8):3103-9. PubMed ID: 3958490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin.
    Krönke M; Schlick E; Waldmann TA; Vitetta ES; Greene WC
    Cancer Res; 1986 Jul; 46(7):3295-8. PubMed ID: 3011246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotoxins against solid tumors.
    Pirker R
    J Cancer Res Clin Oncol; 1988; 114(4):385-93. PubMed ID: 3045130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of antitumor immunotoxins by liposomal monensin.
    Griffin T; Rybak ME; Recht L; Singh M; Salimi A; Raso V
    J Natl Cancer Inst; 1993 Feb; 85(4):292-8. PubMed ID: 8426373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates.
    Candiani C; Franceschi A; Chignola R; Pasti M; Anselmi C; Benoni G; Tridente G; Colombatti M
    Cancer Res; 1992 Feb; 52(3):623-30. PubMed ID: 1732050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid disrupts the Golgi apparatus and increases the cytosolic routing of specific protein toxins.
    Wu YN; Gadina M; Tao-Cheng JH; Youle RJ
    J Cell Biol; 1994 May; 125(4):743-53. PubMed ID: 8188744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape Enhancers.
    Fuchs H; Weng A; Gilabert-Oriol R
    Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27376327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas.
    Griffin TW; Pagnini PG; McGrath JJ; McCann JC; Houston LL
    J Biol Response Mod; 1988 Dec; 7(6):559-67. PubMed ID: 3265147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediation of reduction of spontaneous and experimental pulmonary metastases by ricin A-chain immunotoxin 45-2D9-RTA with potentiation by systemic monensin in mice.
    Roth JA; Ames RS; Fry K; Lee HM; Scannon PJ
    Cancer Res; 1988 Jun; 48(12):3496-501. PubMed ID: 3259469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.
    Zovickian J; Johnson VG; Youle RJ
    J Neurosurg; 1987 Jun; 66(6):850-61. PubMed ID: 3033171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber.
    Goldmacher VS; Blättler WA; Lambert JM; McIntyre G; Stewart J
    Mol Pharmacol; 1989 Nov; 36(5):818-22. PubMed ID: 2531272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier protein-monensin conjugates: enhancement of immunotoxin cytotoxicity and potential in tumor treatment.
    Colombatti M; Dell'Arciprete L; Chignola R; Tridente G
    Cancer Res; 1990 Mar; 50(5):1385-91. PubMed ID: 2302703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin.
    Griffin TW; Pagnini PG; Houston LL
    J Biol Response Mod; 1987 Oct; 6(5):537-45. PubMed ID: 3500277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.